Lawrence C. Brody mainly focuses on Genetics, Cancer, Breast cancer, Internal medicine and Mutation. His Genetics and Genetic testing, Germline mutation, Single-nucleotide polymorphism, Allele frequency and Gene investigations all form part of his Genetics research activities. His Cancer study combines topics from a wide range of disciplines, such as Ashkenazi jews, Allele, Family history and Risk factor.
His Breast cancer study incorporates themes from Genetic counseling and Breast cancer susceptibility genes. His Internal medicine study combines topics in areas such as Methylenetetrahydrofolate reductase, Endocrinology, Methionine synthase activity and Oncology. His Oncology research includes elements of Ovarian cancer and Mutation.
Lawrence C. Brody mostly deals with Genetics, Internal medicine, Single-nucleotide polymorphism, Gene and Genotype. His Genetics study frequently intersects with other fields, such as Molecular biology. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Endocrinology and Oncology.
His research in Oncology tackles topics such as Breast cancer which are related to areas like Mutation, Germline mutation and Genetic testing. He interconnects Neural tube defect, Odds ratio and Cohort in the investigation of issues within Genotype. The various areas that he examines in his Cancer study include Ashkenazi jews, Cancer research and Family history.
Lawrence C. Brody focuses on Genetics, Single-nucleotide polymorphism, Copy-number variation, Genome-wide association study and Endocrinology. His Neural tube, Genetic variation, Candidate gene, Human genetics and Variant type investigations are all subjects of Genetics research. His Single-nucleotide polymorphism research integrates issues from Odds ratio, DNA microarray, Histone and Methyltransferase.
The study incorporates disciplines such as SNP, Genetic model, Linkage disequilibrium, Genetic association and Computational biology in addition to Genome-wide association study. His biological study spans a wide range of topics, including Internal medicine and Polymorphism. Internal medicine is closely attributed to Methylenetetrahydrofolate reductase in his work.
His main research concerns Computational biology, Genetic testing, Gene flow, Genetic architecture and Genetic predisposition. As part of one scientific family, he deals mainly with the area of Computational biology, narrowing it down to issues related to the SNP, and often Genetic association. His work deals with themes such as Disease gene, Medical physics, Massive parallel sequencing and Family medicine, which intersect with Genetic testing.
His Genetic predisposition research is multidisciplinary, relying on both Methylenetetrahydrofolate reductase, Neural tube, Anencephaly, B vitamins and Spina bifida. His Neural tube research is under the purview of Genetics. He performs integrative study on Genetics and Workgroup in his works.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Jeffery P. Struewing;Patricia Hartge;Sholom Wacholder;Sonya M. Baker.
The New England Journal of Medicine (1997)
Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis.
Joseph G. Hacia;Lawrence C. Brody;Mark S. Chee;Stephen P.A. Fodor.
Nature Genetics (1996)
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals
Jeffery P. Struewing;Dvorah Abeliovich;Tamar Peretz;Naaman Avishai.
Nature Genetics (1995)
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage
Ronit I. Yarden;Sherly Pardo-Reoyo;Magda Sgagias;Kenneth H. Cowan.
Nature Genetics (2002)
A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene: Implications for Presymptomatic Testing and Screening
Donna Shattuck Eidens;Melody Mcclure;Jacques Simard;Fernand Labrie.
JAMA (1995)
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1
C. Oddoux;J. P. Struewing;C. M. Clayton;S. Neuhausen.
Nature Genetics (1996)
Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays
J. G. Hacia;J.-B. Fan;O. Ryder;Li Jin;Li Jin.
Nature Genetics (1999)
A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4
Terri H. Beaty;Jeffrey C. Murray;Mary L. Marazita;Ronald G. Munger.
Nature Genetics (2010)
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer
Lucio H. Castilla;Lucio H. Castilla;Fergus J. Couch;Michael R. Erdos;Kent F. Hoskins.
Nature Genetics (1994)
BRCA1 interacts with components of the histone deacetylase complex
Ronit I. Yarden;Lawrence C. Brody.
Proceedings of the National Academy of Sciences of the United States of America (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
National Institutes of Health
University of California, Berkeley
University of Tennessee at Knoxville
Emory University
University of Bergen
National Institutes of Health
National Institutes of Health
National Institutes of Health
National Institutes of Health
University Of Thessaly
Apple (United States)
University of Michigan–Ann Arbor
Central South University
Yasouj University
Xinyang Normal University
École Polytechnique Fédérale de Lausanne
National Institutes of Health
Rockefeller University
Federal University of Toulouse Midi-Pyrénées
The University of Texas at Austin
Council of Scientific and Industrial Research
Clemson University
Baylor College of Medicine
Linköping University
Peter MacCallum Cancer Centre